Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6
Court, M. H.; Almutairi, F. E.; Greenblatt, D. J.; Hazarika, S.; Sheng, H.; Klein, K.; Zanger, U. M.; Bourgea, J.; Patten, C. J.; Kwara, A.
- 期刊名称Antimicrobial Agents and Chemotherapy
- 作者Court, M. H.; Almutairi, F. E.; Greenblatt, D. J.; Hazarika, S.; Sheng, H.; Klein, K.; Zanger, U. M.; Bourgea, J.; Patten, C. J.; Kwara, A.
- 卷第58卷
- 期第7期
- 印刷ISSN0066-4804
- 电子ISSN1098-6596
- 文件大小1079.61KB
- 发表时间2014-07-01
- DOI10.1128/AAC.02532-14
- 页码4145-4152